BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 14684844)

  • 1. Regulation of inhibitory protein-kappaB and monocyte chemoattractant protein-1 by angiotensin II type 2 receptor-activated Src homology protein tyrosine phosphatase-1 in fetal vascular smooth muscle cells.
    Wu L; Iwai M; Li Z; Shiuchi T; Min LJ; Cui TX; Li JM; Okumura M; Nahmias C; Horiuchi M
    Mol Endocrinol; 2004 Mar; 18(3):666-78. PubMed ID: 14684844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NF-κB and CREB are required for angiotensin II type 1 receptor upregulation in neurons.
    Haack KK; Mitra AK; Zucker IH
    PLoS One; 2013; 8(11):e78695. PubMed ID: 24244341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of NF-kappa B is required for hypertrophic growth of primary rat neonatal ventricular cardiomyocytes.
    Purcell NH; Tang G; Yu C; Mercurio F; DiDonato JA; Lin A
    Proc Natl Acad Sci U S A; 2001 Jun; 98(12):6668-73. PubMed ID: 11381115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incorporation of Phosphorylated Tyrosine into Proteins: In Vitro Translation and Study of Phosphorylated IκB-α and Its Interaction with NF-κB.
    Chen S; Maini R; Bai X; Nangreave RC; Dedkova LM; Hecht SM
    J Am Chem Soc; 2017 Oct; 139(40):14098-14108. PubMed ID: 28898075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curcumin Inhibits Lysophosphatidic Acid Mediated MCP-1 Expression via Blocking ROCK Signalling.
    Zhou Y; Little PJ; Xu S; Kamato D
    Molecules; 2021 Apr; 26(8):. PubMed ID: 33923651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of Concern: NF-κB and CREB Are Required for Angiotensin II Type 1 Receptor Upregulation in Neurons.
    PLOS ONE Editors
    PLoS One; 2023; 18(11):e0294092. PubMed ID: 37917764
    [No Abstract]   [Full Text] [Related]  

  • 7. Statement of Retraction: Angiotensin II receptor antagonist olmesartan and NF-kappaB inhibitor as cytotoxic and apoptotic agents in MCF-7 human cell line.
    J Chemother; 2024 Jan; ():1. PubMed ID: 38166589
    [No Abstract]   [Full Text] [Related]  

  • 8. Renin-Angiotensin System Components and Arachidonic Acid Metabolites as Biomarkers of COVID-19.
    Ghimire B; Pour SK; Middleton E; Campbell RA; Nies MA; Aghazadeh-Habashi A
    Biomedicines; 2023 Jul; 11(8):. PubMed ID: 37626615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardioprotective Mechanisms against Reperfusion Injury in Acute Myocardial Infarction: Targeting Angiotensin II Receptors.
    Méndez-Valdés G; Pérez-Carreño V; Bragato MC; Hundahl M; Chichiarelli S; Saso L; Rodrigo R
    Biomedicines; 2022 Dec; 11(1):. PubMed ID: 36672525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CGP42112: the full AT2 receptor agonist and its role in the renin-angiotensin-aldosterone system: no longer misunderstood.
    Restrepo YM; Noto NM; Speth RC
    Clin Sci (Lond); 2022 Nov; 136(21):1513-1533. PubMed ID: 36326719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II type 2 receptor agonist Compound 21 attenuates pulmonary inflammation in a model of acute lung injury.
    Menk M; Graw JA; von Haefen C; Steinkraus H; Lachmann B; Spies CD; Schwaiberger D
    J Inflamm Res; 2018; 11():169-178. PubMed ID: 29750051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain Renin-Angiotensin System and Microglial Polarization: Implications for Aging and Neurodegeneration.
    Labandeira-Garcia JL; Rodríguez-Perez AI; Garrido-Gil P; Rodriguez-Pallares J; Lanciego JL; Guerra MJ
    Front Aging Neurosci; 2017; 9():129. PubMed ID: 28515690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. c-kit(+)AT2R(+) Bone Marrow Mononuclear Cell Subset Is a Superior Subset for Cardiac Protection after Myocardial Infarction.
    Du M; Schmull S; Zhang W; Wang C; Lian F; Chen Y; Xue S
    Stem Cells Int; 2016; 2016():4913515. PubMed ID: 27429622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II Type 2-Receptor Agonist C21 Reduces Proteinuria and Oxidative Stress in Kidney of High-Salt-Fed Obese Zucker Rats.
    Patel SN; Ali Q; Hussain T
    Hypertension; 2016 May; 67(5):906-15. PubMed ID: 27021008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of angiotensin II type 2 receptor suppresses TNF-α-induced ICAM-1 via NF-кB: possible role of ACE2.
    Zhu L; Carretero OA; Xu J; Harding P; Ramadurai N; Gu X; Peterson E; Yang XP
    Am J Physiol Heart Circ Physiol; 2015 Sep; 309(5):H827-34. PubMed ID: 26163449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The CD4(+) AT2R(+) T cell subpopulation improves post-infarction remodelling and restores cardiac function.
    Skorska A; von Haehling S; Ludwig M; Lux CA; Gaebel R; Kleiner G; Klopsch C; Dong J; Curato C; Altarche-Xifró W; Slavic S; Unger T; Steinhoff G; Li J; David R
    J Cell Mol Med; 2015 Aug; 19(8):1975-85. PubMed ID: 25991381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compound 21, a selective agonist of angiotensin AT2 receptors, prevents endothelial inflammation and leukocyte adhesion in vitro and in vivo.
    Sampson AK; Irvine JC; Shihata WA; Dragoljevic D; Lumsden N; Huet O; Barnes T; Unger T; Steckelings UM; Jennings GL; Widdop RE; Chin-Dusting JP
    Br J Pharmacol; 2016 Feb; 173(4):729-40. PubMed ID: 25560767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AT2 receptors targeting cardiac protection post-myocardial infarction.
    Kaschina E; Lauer D; Schmerler P; Unger T; Steckelings UM
    Curr Hypertens Rep; 2014 Jul; 16(7):441. PubMed ID: 24792092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AT(2) receptor and tissue injury: therapeutic implications.
    Namsolleck P; Recarti C; Foulquier S; Steckelings UM; Unger T
    Curr Hypertens Rep; 2014 Feb; 16(2):416. PubMed ID: 24414230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the AT(2) receptor agonist C21 on blood pressure and beyond.
    Foulquier S; Steckelings UM; Unger T
    Curr Hypertens Rep; 2012 Oct; 14(5):403-9. PubMed ID: 22836386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.